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Abstract Tail-anchored proteins form a distinct class of mem-
brane proteins that have a single membrane anchor sequence at
their C-terminus, the tail-anchor. Their N-terminal portion is
exposed to the cytosol. We have studied the roles of tail-anchor
domains of proteins residing in the mitochondrial outer mem-
brane. Four distinct functions of the tail-anchor domain were
identi¢ed. First, the domain mediates the targeting to mitochon-
dria in a process that probably requires a net positive charge at
the C-terminally £anking segment. Second, tail-anchor domains
facilitate the insertion into the mitochondrial outer membrane.
Third, the tail-anchor is responsible for the assembly of the
respective protein into functional multi-subunit complexes; and
fourth, tail-anchor domains can stabilize such complexes.
' 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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1. Introduction
Proteins anchored to the membrane by their C-terminus
form a distinct class of integral membrane proteins. These
proteins consist of a hydrophilic N-terminal part of variable
size which is exposed towards the cytosol and a tail-anchor
containing a single transmembrane domain (TMD) which is
£anked on both sides by short sequences usually containing
charged residues [1]. Tail-anchored proteins are found in es-
sentially all membranes abutting the cytosol [2].
In mitochondria tail-anchored proteins are present in the
outer membrane, and like all proteins of this membrane, they
are encoded by nuclear DNA, synthesized on cytosolic ribo-
somes and subsequently transported to their site of function.
Tail-anchored proteins in the mitochondrial outer membrane
include: Fis1, a protein involved in ¢ssion of mitochondria
[3] ; three small subunits of the TOM complex (Tom5, Tom6,
Tom7) that interact with Tom40 to form the TOM core com-
plex [4^7] ; regulators of apoptosis belonging to the Bcl-2
family [8] ; the mitochondrial form of cytochrome b5 (cyt b5)
[9,10] ; and an alternatively spliced isoform of vesicle-associ-
ated membrane protein/synaptobrevin (VAMP-1B) [11].
Tail-anchored proteins do not exhibit sequence similarity in
their tail domains, rather the mitochondrial targeting informa-
tion contained therein appears to be encoded in the special
structural features of the tail domain. The TMDs of these tails
are moderately hydrophobic, relatively short (6 20 residues),
and the £anking regions have positive charges on both sides
[2].
The role(s) of tail-anchor domains and the structural fea-
tures that allow them to ful¢ll their various roles are only
partially understood. Open questions are: Is the only function
of the tail-anchor domain to target the hydrophilic domain to
the surface of the mitochondria and hold it at the mitochon-
drial outer membrane? Do tail-anchor domains interact in a
sequence-speci¢c fashion with other subunits with which they
assemble into oligomeric complexes and do they have a role in
the stabilization of such assemblies?
In this study we have used the yeast Saccharomyces cerevi-
siae to investigate the various functions of tail-anchor do-
mains. Mutated versions of tail-anchored proteins were con-
structed and their correct intracellular sorting was veri¢ed by
an in vivo functional complementation assay in combination
with subcellular fractionation. Our results imply that a net
positive charge in the C-terminal £anking region of the
TMD is essential for a function as mitochondrial targeting
signal. Remarkably, upon replacing the tail-anchor domain
of Fis1 by that of Tom5 or Tom6 a functional Fis1 was
obtained. Thus, the tail-anchor domain of Fis1 appears to
play only a limited role, if any, in the particular function of
this protein. A Tom6 variant in which the cytosolic domain
was replaced by that of Fis1 could ful¢ll the function of au-
thentic Tom6 in stabilizing the TOM complex. Moreover, a
Tom5 variant with a similar exchange could partially replace
the native Tom5 in promoting preprotein import. Hence, in
addition to their functions in targeting the proteins to the
mitochondria and anchoring the cytosolic domain in the outer
membrane, tail-anchor domains form a structural element
which is required for the assembly into and the stabilization
of a multi-subunit complex.
2. Materials and methods
2.1. Yeast strains and growth methods
Standard genetic techniques were used for growth and manipula-
tion of yeast strains [12]. Transformation of yeast was carried out
using the lithium acetate method. Yeast cells were grown under aero-
bic conditions on YPD (1% [w/v] yeast extract, 2% [w/v] bactopep-
tone, 2% glucose) or on YPG (1% [w/v] yeast extract, 2% [w/v] bac-
topeptone, 3% glycerol) medium. The Fis1 null strain, ADM552, and
its corresponding parental strain ADM551 (a kind gift of Dr. J. Shaw)
[3] as well as the Tom5 null strain and its corresponding parental
strain (a kind gift of N. Pfanner) [5] were used. The Tom6 null strain
and its corresponding parental strain BY4743 were obtained from
Research Genetics (Huntsville, AL, USA).
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2.2. Recombinant DNA techniques
Fis1 variants and hybrid proteins were constructed by polymerase
chain reaction ampli¢cation of the relevant DNA fragments and stan-
dard molecular biology techniques. DNA fragments encoding the
protein of interest were introduced into the multicopy plasmid
pYX132 (Invitrogen). All constructs were sequenced to ensure their
correct DNA sequence.
2.3. Fluorescence microscopy
A Fis1 null strain was co-transformed with plasmid pVT100U-
mtGFP expressing mitochondria-targeted green £uorescent protein
[13] and a plasmid with another genetic marker encoding a Fis1 var-
iant. After selection on the appropriate markers, cells were grown for
16 h to exponential phase in liquid selective glucose medium at 30‡C
and analyzed by standard £uorescence microscopy. Classi¢cation and
quanti¢cation of the morphology phenotypes were performed without
knowledge of strain identity at the time of analysis. For quanti¢cation
of the phenotype, at least 100 cells were analyzed in three independent
experiments, and the average was calculated.
2.4. Biochemical methods
Mitochondria for in vitro import experiments were prepared by
di¡erential centrifugation as described [14]. Radiolabeled precursor
proteins were synthesized in rabbit reticulocyte lysate in the presence
of [35S]methionine (Amersham) after in vitro transcription by SP6
polymerase from pGEM4 vectors containing the gene of interest. Im-
port experiments were performed in a bu¡er containing 250 mM
sucrose, 0.25 mg/ml bovine serum albumin, 80 mM KCl, 5 mM
MgCl2, 10 mM MOPS^KOH, 2 mM NADH, 2 mM ATP, pH 7.2.
Protease treatment of mitochondria was performed by incubation
with proteinase K for 15 min on ice, followed by addition for
5 min of 1 mM phenylmethylsulfonyl £uoride (PMSF). Import was
analyzed by sodium dodecyl sulfate^polyacrylamide gel electrophore-
sis (SDS^PAGE), autoradiography and phosphorimaging (Fuji BAS
3000).
2.5. Blue native gel electrophoresis (BNGE)
Mitochondria were lysed in 50 Wl detergent-containing bu¡er (1%
digitonin in 20 mM Tris^HCl, 0.1 mM EDTA, 50 mM NaCl, 10%
glycerol, 1 mM PMSF, pH 7.4). After incubation at 4‡C for 10 min
and a clarifying spin (20 min, 36 700Ug), 5 Wl sample bu¡er (5% (w/v)
Coomassie brilliant blue G-250, 100 mM Bis-Tris, 500 mM 6-amino-
caproic acid, pH 7.0) was added, and the mixture was analyzed on a
6^13% gradient blue native gel [15].
3. Results
3.1. A net positive charge at the C-terminus of Fis1 is essential
for mitochondrial targeting
Fis1 contains four positively charged amino acid residues in
the segment located C-terminally to the TMD (Fig. 1A). Pos-
itive charges in this segment of another tail-anchored protein,
Tom5, were suggested to play an important role in the target-
ing of the protein to mitochondria in mammalian but not in
yeast cells [16]. To check whether this is a general property of
tail-anchored proteins, we investigated the importance of the
positive charges in the targeting and function of Fis1. To that
end, two arginine residues, Arg154 and Arg155, were replaced
by glutamine residues reducing the net positive charge to +2
(Fig. 1A). The resulting Fis1 variant (Fis1-2Gln) was targeted
to mitochondria in vivo as was demonstrated by subcellular
fractionation (Fig. 1B). In addition, this variant was able to
fully complement the morphology phenotype of ¢s1 null
strain (Table 1). When the net charge in the C-terminal seg-
ment was made neutral by mutating all four basic amino acids
to glutamine residues (Fis1-4Gln, Fig. 1A) the vast majority
of the resulting protein was in non-mitochondrial compart-
ments (Fig. 1C). Hence, a net positive charge in the C-termi-
nal segment appears to be crucial for mitochondrial targeting
in yeast. The small amount of Fis1-4Gln molecules that were
targeted to mitochondria was su⁄cient to complement the
morphology phenotype of ¢s1 null strain (Table 1). This sug-
gests that the positive charge at the C-terminal segment is
required for targeting to mitochondria, but not for the func-
tion of Fis1, once it is present in the membrane.
Note that the levels of expression of Fis1-4Gln are higher
than those of wild type Fis1 or Fis1-2Gln. A recent publica-
tion on the characterization of the mammalian homologue of
Fis1, hFis1, suggested that an increased level of mitochondrial
hFis1 strongly promotes mitochondrial ¢ssion, resulting in an
accumulation of fragmented mitochondria [17]. We speculate
that the remarkable di¡erences in the levels of expression
Fig. 1. A net positive charge at the C-segment of Fis1 is crucial for
mitochondrial targeting. A: The sequences of the tail domains of
native Fis1 and the two charge variants are presented. B,C: Fis1
null cells transformed with a vector encoding either authentic Fis1
or the indicated variants of Fis1 were ruptured by vortexing in the
presence of glass beads. A mitochondrial and a post-mitochondrial
fraction were obtained by di¡erential centrifugation (M and S, re-
spectively) and were subjected to SDS^PAGE and immunoblotting.
The antibodies used were directed against the cytosolic domain of
Fis1, a control marker protein for the cytosol (hexokinase), and the
mitochondrial outer membrane protein Tom40.
Table 1
Complementation analysis of Fis1 variants
Yeast strain: wild type or v¢s1 transformed with a plasmid
encoding the indicated protein
% of cells with normal reticular mitochondrial morphology
Wild type 96
v¢s1+Fis1 96
v¢s1+Fis1-4Gln 95
v¢s1+Fis1-2Gln 89
v¢s1+Fis1(cyt)-Tom5C 79
v¢s1+Fis1(cyt)-Tom6C 69
v¢s1+empty plasmid 0
The percentage of cells with wild type-like mitochondrial morphology was determined using £uorescence microscopy.
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among various Fis1 variants are the result of a tight regula-
tion of the levels of functional Fis1 in the outer membrane.
An over-expression of the functional wild type Fis1 or Fis1-
2Gln might harm the cells and therefore their level of expres-
sion is regulated. In contrast, the mis-targeted Fis1-4Gln is
not ‘harmful’ outside the mitochondria and hence, can be
present in higher amounts.
3.2. The tail-anchor domain of Fis1 does not have a sequence-
speci¢c role
We investigated whether a tail-anchor domain of a partic-
ular tail-anchored outer membrane protein can functionally
replace the signal-anchor domain of another one. Chimeric
proteins were constructed, in which the cytosolic domain of
Fis1 (amino acid residues 1^123) was fused to the tail-anchor
domain of Tom5 (residues 21^51) or Tom6 (residues 31^60)
(Fig. 2A). Both proteins, Fis1(cyt)-Tom5C and Fis1(cyt)-
Tom6C, were targeted to mitochondria (Fig. 2A). Thus, tail-
anchor domains of di¡erent proteins can be exchanged with-
out losing their targeting and anchoring functions. Since the
cytosolic domain of Fis1 does not contain a mitochondrial
targeting signal [3], these results imply that the signal-anchor
domains of both Tom5 and Tom6 are su⁄cient for mitochon-
drial targeting.
Tom5 and Tom6 are components of the TOM core complex
[18,19]. We asked whether the tail-anchor domains of both
proteins are su⁄cient to promote the assembly of the above
fusion proteins into the TOM machinery. The TOM core
complex isolated from strains harboring either Fis1(cyt)-
Tom5C or Fis1(cyt)-Tom6C was analyzed by BNGE. The
vast majority of both proteins assembled into the TOM com-
plex as both proteins were present in the 410 kDa TOM
complex together with Tom40 (Fig. 2B). Upon quanti¢cation
of the immunodecoration we found that only about 6% of the
expressed proteins migrated as unassembled low molecular
weight species. Thus, the tail-anchor domains of both Tom6
and Tom5 are su⁄cient for the assembly of the fusion pro-
teins into the TOM complex.
We tested whether expression of either Fis1(cyt)-Tom5C or
Fis1(cyt)-Tom6C would restore the defective morphology of
mitochondria in the ¢s1 null strain. Based on quantitative
Western blotting we estimated that mitochondria expressing
Fis1(cyt)-Tom5C or Fis1(cyt)-Tom6C contain seven- to eight-
fold more Fis1 molecules as compared to Fis1wt (our unpub-
lished results). Although only minor amounts of these mole-
cules were not assembled into the TOM complex (see above),
both proteins were able to partially complement the morphol-
ogy phenotype of v¢s1 strain (Fig. 2C and Table 1). Thus, we
conclude that those molecules of Fis1 fusion proteins that
were not assembled into the TOM complex can be as active
as Fis1 wild type in mediating ¢ssion of mitochondria. The
tail-anchor domain of Fis1 is probably not involved in se-
quence-speci¢c interactions that are essential for the function
of the protein. These conclusions are in line with a recent
publication suggesting that the region mediating mitochon-
drial ¢ssion resides within the ¢rst 31 amino acids of the N-
terminal cytosolic domain of human Fis1 [17].
3.3. The tail-anchor domain of Tom6 acts as a stabilizer of the
TOM complex
Tom6 stabilizes the TOM core complex and forms a link
between Tom22 and Tom40 [4,18,20]. Deletion of Tom6 re-
sulted in a dramatic shift in the mobility of Tom40 upon
analysis by BNGE [18]. About 80% of Tom40 molecules in
the tom6 null strain migrated as a 100 kDa complex (Fig. 3).
Since Fis1(cyt)-Tom6C could assemble into the TOM com-
plex, we asked whether this hybrid protein can functionally
Fig. 2. The tail-anchor domains of Tom5 and Tom6 but not their
cytosolic domains are required for targeting and assembly of the
proteins. A: Fis1 null cells transformed with native or with the indi-
cated variants of Fis1 were sub-fractionated as described in the
legend to Fig. 1. Fis1(cyt), the cytosolic domain of Fis1. B: Mito-
chondria isolated from a ¢s1 null strain transformed with either
Fis1(cyt)-Tom5C or Fis1(cyt)-Tom6C were lysed with digitonin and
analyzed by BNGE. The amounts of mitochondrial proteins applied
(Wg) are indicated. Blots were immunodecorated with antibodies
against either Tom40 or Fis1. The TOM complex (TOM) and the
unassembled Fis1 variants (Fis1) are indicated. C: Fis1(cyt)-Tom5C
can partially complement the mitochondrial morphology phenotype
of the vFis1 strain. Cells of the indicated strains (containing mito-
chondria-targeted GFP) were analyzed by £uorescence (left) and
phase contrast (right) microscopy.
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replace the native Tom6. When Fis1(cyt)-Tom6C was trans-
formed into a tom6 null strain most of the TOM core com-
plexes regained their stability (Fig. 3). Thus, the tail-anchor
domain of Tom6 is su⁄cient to ful¢ll the structural role of the
protein.
3.4. The tail-anchor, but not the cytosolic domain of Tom5, is
required for function of the protein
Deletion of the gene encoding Tom5 in yeast was reported
to result in cells that cannot grow at the elevated temperature
37‡C [5]. As a measure for functionality of the protein we
asked whether expression of Fis1(cyt)-Tom5C in the tom5
null strain is able to complement this growth phenotype. We
observed a complete restoration of growth at 30‡C, and a
partial restoration of growth at 37‡C (Fig. 4A).
Tom5 was suggested to link the surface receptors for pre-
proteins with the general insertion pore [5,21]. Mitochondria
lacking Tom5 were observed to be severely impaired in their
ability to import precursor proteins in vitro [5]. The expres-
sion of Fis1(cyt)-Tom5C in tom5 null cells led to partial alle-
viation of this import defect (Fig. 4B). Taken together, the
cytosolic domain of Tom5 appears not to be essential for the
function of the protein.
4. Discussion
We report here on multiple functions of the tail-anchor
domains of mitochondrial outer membrane proteins. Initially,
the domain mediates the targeting of the respective precursor
protein to mitochondria. The importance of positive net
charge in the C-terminal segment for correct mitochondrial
targeting has been demonstrated before in mammalian mito-
chondria, but was questioned regarding targeting to yeast mi-
tochondria [16]. An example in mammalian cells for the im-
portance of positive charges at the C-terminal segment is
provided by cyt b5 and VAMP-1. Both of these proteins exist
in two homologous isoforms that are localized speci¢cally
either to the mitochondrial outer membrane or to the endo-
Fig. 3. The tail-anchor domain of Tom6 is su⁄cient for the TOM-
stabilizing function of the protein. Mitochondria isolated from a
wild type strain and from a tom6 null strain transformed with either
empty vector (vtom6+pYX132) or vector encoding Fis1(cyt)-Tom6C
(vtom6+Fis1(cyt)-Tom6C) were lysed with digitonin and analyzed
by BNGE. The amounts of mitochondrial proteins applied (Wg) are
indicated. Blots were immunodecorated with antibodies against
Tom40. The native 410 kDa TOM core complex (TOM) and the
100 kDa form of Tom40 (100K) are indicated.
Fig. 4. The tail-anchor domain of Tom5 can partially complement
the function of authentic Tom5. A: The fusion protein Fis1(cyt)-
Tom5C can partially rescue the temperature-sensitive phenotype of
a tom5 null strain. vtom5 cells, their isogenic wild type, and vtom5
cells transformed with a plasmid encoding Fis1(cyt)-Tom5C were
tested by dilution in 10-fold increments for their ability to grow on
YPD medium at either 30‡C or 37‡C. B: Fis1(cyt)-Tom5C can par-
tially rescue the import phenotype of tom5 null strain. Radiolabeled
precursor proteins of the ADP/ATP carrier (AAC) and of pSu9-
DHFR (pSu9-DHFR) were incubated with isolated mitochondria at
25‡C for the indicated time periods. After import the samples were
treated with proteinase K and mitochondria were re-isolated. Im-
ported proteins were analyzed by SDS^PAGE and autoradiography.
The amount of precursor proteins imported into wild type mito-
chondria for the longest time period was set to 100%.
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plasmic reticulum. In both cases it has been shown that the
mitochondrial localization requires a lack of net negative
charge at the C-terminal segment [2,11,22]. We could show
that such positive charges are crucial for targeting of Fis1
to mitochondria in yeast cells.
The observation that tail-anchor domains of Tom5 and
Tom6 are functionally interchangeable with that of Fis1 is
quite surprising considering the lack of sequence similarity
in these regions. Although the tail-anchor domain has a cru-
cial role in topogenic signaling, it appears to play only a
limited role in the speci¢c function of Fis1.
Tom5 and Tom6 are unique in the sense that the tail-an-
chor domain can ful¢ll the function of the protein even when
the cytosolic domain is replaced by an unrelated passenger
domain. In the case of Tom6 this might have been expected
considering the proposed function of the protein in linking
membrane-embedded Tom components [4,18,20]. For Tom5,
however, the ability of the tail-anchor domain to largely ful¢ll
the function of the whole protein is quite surprising. The
cytosolic domain of Tom5 has a net negative charge and
was suggested to be part of an ‘acid chain’ that guides the
sequential transport of positively charged mitochondrial pre-
sequences [5,21]. As Tom5 was found to be in the vicinity of
preproteins in transit [5], it is tempting to speculate that the
tail-anchor domain of Tom5 builds part of the preprotein
translocation pore.
Recently, Horie et al. analyzed in detail the targeting signal
of Tom5 in yeast [23]. It was shown that the positively
charged C-terminal anchor segment of Tom5 was dispensable
not only for targeting, but also for the integration into the
TOM complex and for the function of the protein in yeast.
Tom6, another tail-anchored protein, which plays a critical
role in modulating the stability of the TOM complex [18],
has a net negative charge in its C-segment. Thus, Tom5 rep-
resents a unique case among the tail-anchored family TOM
components. In agreement with our results, proteins dispersed
in the outer membrane, in contrast to the Tom complex com-
ponent Tom5, do require a net positive charge to be inserted
into the correct membrane.
In conclusion, we demonstrate that the tail-anchor domain
can have four distinct functions. First, it is su⁄cient to target
a passenger domain to the mitochondria in a process that
probably requires a net positive charge at the C-terminus.
Second, this domain can mediate the correct insertion of the
protein into the outer membrane so that the N-terminal do-
main is facing the cytosol. Third, as shown for the TOM
complex, the tail-anchor can act as an assembly signal or a
domain that mediates assembly. Finally, it has a speci¢c role
either as a structural stabilization element or as a component
of a preprotein conducting pore.
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